Fundraising FoxSynGen
Sacramento, US · Founded 2012 · Delaware corporation · 1 known investors
Find your way into SynGen
Sign up to see every warm intro you have to SynGen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SynGen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SynGen was founded in 2012 by George Barry and Philip H. Coelho.
GB
George BarryCo-Founder of Issuer
PH
Philip H. CoelhoChief Technology Officer and Co-Founder of Issuer
CN
Chuck NovakVice President and Chief Financial Officer of the Issuer
WG
William GerberChief Executive Officer and President of Issuer
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$12.2M disclosed across 11 of 12 rounds · 2013–2017
▶$400KraisedJun 2017 · 1 investors · BiotechnologyRule 506(b)
▶$400KraisedJun 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Vic SchmittDirector
- Philip H. CoelhoExecutive Officer
- Chuck NovakExecutive Officer
- George BarryDirector
- Carl GoldfischerDirector
- William GerberExecutive Officer, Director
- Woodrow A. Myers, Jr.Director
- Offering amount
- $400K
- Amount sold
- $400K
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$500KraisedApr 2017 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedApr 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William GerberExecutive Officer, Director
- George BarryDirector
- Philip H. CoelhoExecutive Officer
- Woodrow A. Myers, Jr.Director
- Carl GoldfischerDirector
- Chuck NovakExecutive Officer
- Vic SchmittDirector
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$500KraisedMar 2017 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedMar 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Woodrow A. Myers, Jr.Director
- Philip H. CoelhoExecutive Officer
- Carl GoldfischerDirector
- Chuck NovakExecutive Officer
- William GerberExecutive Officer, Director
- Vic SchmittDirector
- George BarryDirector
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$500KraisedFeb 2017 · 2 investors · BiotechnologyRule 506(b)
▶$500KraisedFeb 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chuck NovakExecutive Officer
- William GerberExecutive Officer, Director
- Woodrow A. Myers, Jr.Director
- Carl GoldfischerDirector
- Vic SchmittDirector
- George BarryDirector
- Philip H. CoelhoExecutive Officer
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$500KraisedJan 2017 · 2 investors · BiotechnologyRule 506(b)
▶$500KraisedJan 2017 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Woodrow A. Myers, Jr.Director
- William GerberExecutive Officer, Director
- Philip H. CoelhoExecutive Officer
- George BarryDirector
- Carl GoldfischerDirector
- Vic SchmittDirector
- Chuck NovakExecutive Officer
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$1MraisedNov 2016 · 3 investors · BiotechnologyRule 506(b)
▶$1MraisedNov 2016 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Philip H. CoelhoExecutive Officer
- Carl GoldfischerDirector
- George BarryDirector
- Vic SchmittDirector
- Chuck NovakExecutive Officer
- William GerberExecutive Officer, Director
- Woodrow A. Myers, Jr.Director
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$1MraisedJul 2016 · 3 investors · BiotechnologyRule 506(b)
▶$1MraisedJul 2016 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Carl GoldfischerDirector
- Vic SchmittDirector
- Chuck NovakExecutive Officer
- Philip H. CoelhoExecutive Officer
- George BarryDirector
- William GerberExecutive Officer, Director
- Woodrow A. Myers, Jr.Director
- Offering amount
- $2M
- Amount sold
- $1M
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$1.6MraisedMay 2016 · 3 investors · BiotechnologyRule 506(b)
▶$1.6MraisedMay 2016 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chuck NovakExecutive Officer
- George BarryDirector
- Vic SchmittDirector
- Carl GoldfischerDirector
- William GerberExecutive Officer, Director
- Woodrow A. Myers, Jr.Director
- Philip H. CoelhoExecutive Officer
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded SynGen?
- SynGen was founded by George Barry, Philip H. Coelho in 2012.
- Who are SynGen's investors?
- SynGen's investors include Bay City Capital.
- How much funding has SynGen raised?
- SynGen has disclosed $12.2M raised across 11 of its 12 known rounds.
- Where is SynGen headquartered?
- SynGen is headquartered in Sacramento, US.